Sort
85,873 grants matching “alzheimers”
Microglia targeted interventions in prodromal Alzheimer's disease stage
$816,586Julia Tcw · Boston University Medical Campus · R01 · FY2024 · AG
Cross-study analysis of coordinated randomized clinical trials for weight managem
$816,583Steven H. Belle · University Of Pittsburgh At Pittsburgh · R01 · FY2015 · HL
Cognitive Resilience among Older Samoans
$816,531Becca R Levy · Yale University · R01 · FY2023 · AG
Clinical Core
$816,417Hillel Grossman · Icahn School Of Medicine At Mount Sinai · P30 · FY2020 · AG
Training in the Molecular Biology of Neurodegeneration and Alzheimer's Disease
$816,403Bruce A Yankner · Harvard Medical School · T32 · FY2018 · AG
Subtype-Selective Metabotropic Glutamate Receptor PET Ligands
$816,387Steven H Liang · Emory University · R61 · FY2023 · NS
Modifiable cardiovascular factors linking type 2 diabetes and Alzheimer's disease
$816,355Antonio Convit · New York University School Of Medicine · R01 · FY2020 · AG
Administrative Core
$816,220Oscar L. Lopez · University Of Pittsburgh At Pittsburgh · P30 · FY2022 · AG
Clinical Core
$816,097Brian Stephen Appleby · Cleveland Clinic Lerner Com-Cwru · P30 · FY2024 · AG
Atypical astrocytes in aging and Alzheimer's Disease
$816,096Chris G Dulla · Tufts University Boston · R01 · FY2025 · AG
Physical activity, sedentary behavior, and sleep in the ACT cohort: The 24-hour activity cycle
$816,081Dori Rosenberg · Kaiser Foundation Research Institute · U19 · FY2021 · AG
Core B: Clinical Core
$816,012John Morris · Washington University · P01 · FY2019 · AG
Health Literacy and Cognitive Function among Middle-Aged Adults: The MidCog Study
$815,886Michael S Wolf · Northwestern University At Chicago · R01 · FY2021 · AG
Characterization of AD-related endolysosomal dysfunction in human neural cells
$815,882Jessica Elaine Young · University Of Washington · R01 · FY2025 · AG
Understanding Biological and Lifestyle Contributions to Alzheimer's Disease Pathology and Clinical Profiles in Black Women: Defining Prevention Targets in High Risk Groups
$815,871Sarah Banks · University Of California, San Diego · R01 · FY2023 · AG
Microbiome-gut-brain dysfunction in prodromal and symptomatic Lewy body diseases
$815,866Sephira Ryman · Lovelace Biomedical Research Institute · R01 · FY2023 · NS
Primary Care Transformation in Puerto Rico's Physician Organizations Following Hurricane Maria
$815,854Justin W. Timbie · Rand Corporation · R01 · FY2025 · AG
Using geroscience to understand and treat Alzheimer's disease
$815,791Pamela Anne Maher · Salk Institute For Biological Studies · R01 · FY2021 · AG
Tracking the origin of tau pathology
$815,700Heidi Irma Jacobs · Massachusetts General Hospital · R01 · FY2019 · AG
Anatomy of the circle of Willis, cerebral blood flow, and Alzheimer's disease biomarkers in hypertension
$815,676Lidia Glodzik · Weill Medical Coll Of Cornell Univ · R01 · FY2023 · HL
Exploring the Role of the Brain Epigenome: Cognitive Decline and Life Experiences
$815,654David A Bennett · Rush University Medical Center · R01 · FY2012 · AG
Subjective Cognitive Decline in OIder Adults
$815,640Katherine A. Gifford · Vanderbilt University Medical Center · R01 · FY2023 · AG
GMP Production and Extended Toxicology of an Oral Formulation Drug for Alzheimer's Disease
$815,581D. Martin Watterson · Northwestern University At Chicago · U01 · FY2025 · AG
A Squirrel Monkey Model of Alzheimerâs Disease: Developing Behavioral, Blood, and CSF Biomarkers
$815,545William D Hopkins · University Of Tx Md Anderson Can Ctr · R33 · FY2024 · AG
Molecular mechanism of bidirectional transport
$815,493William Olaf Hancock · Pennsylvania State University, The · R35 · FY2021 · GM